Literature DB >> 31812322

Clinical outcomes of PFNA-II in the Asian intertrochanteric fracture patients: Comparison of clinical results according to proximal nail protrusion.

Sung Soo Kim1, Hyeon Jun Kim2, Chan Soo Lee1.   

Abstract

PURPOSE: This study intended to explore the clinical outcomes of PFNA-II, one of the commonly used fixation devices for intertrochanteric fractures and the association of clinical results with the extent of proximal nail protrusion.
MATERIALS AND METHODS: Of 315 cases that underwent internal fixation using PFNA-II between September 2010 and June 2018 among intertrochanteric fracture patients aged over 65 years, a total of 86 patients with an ability to communicate clearly and a minimum follow-up of 6 months were retrospectively reviewed. We classified the subjects according to PFNA-II protrusion over the greater trochanter area on anteroposterior radiographs. Differences between the two groups were examined by comparing demographic characteristics including gender, age, height, weight and BMI, instrumental characteristics including PFNA nail size, nail diameter, blade length and blade position, radiologic characteristics including reduction quality, Dorr type and bone union, and clinical characteristics including GT pain,VAS score and Harris Hip Score (HHS).
RESULTS: A total of 86 cases were divided into 30 (34.9%) in the protrusion group (group A) and 56 (65.1%) in the non-protrusion group (group B). No significant difference was found in demographic characteristics such as gender, age, height, weight and BMI between the two groups. Two groups had no statistically significant difference in PFNA nail length, nail diameter and blade length, but showed a statistically significant difference in blade position. At the latest follow-up, the mean HHS shows no statistically significant difference between the two groups. On the contrary, the number of patients complaining of GT pain and VAS score were statistically significantly higher in group A. Removal of metal implants was performed in two patients in the protrusion group due to a complaint of persistent GT pain.
CONCLUSION: Nail protrusion over the greater trochanter area occurs frequently after the surgical treatment of intertrochanteric fracture using PFNA-II. When the nail protruded into the greater trochanter, the number of patients who clinically complained of pain was statistically significantly high. We recommend a modification to the PFNA-II that would further shorten the proximal nail end suitable for the Asian population to achieve better clinical results in the fixation of intertrochanteric fractures.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Intertrochanteric fracture; Nail protrusion; PFNA-II

Year:  2019        PMID: 31812322     DOI: 10.1016/j.injury.2019.11.040

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  4 in total

1.  Comment on Shi et al.: Association of the lateral wall integrity with clinical outcomes in older patients with intertrochanteric hip fractures treated with the proximal femoral nail anti-rotation-Asia.

Authors:  Xuefeng Zhou; Jiazhao Yang; Shiyuan Fang
Journal:  Int Orthop       Date:  2022-01-13       Impact factor: 3.075

2.  Treatment of Coronal Plane Femoral Intertrochanteric Fractures with a Microexternal Fixator Combined with Proximal Femoral Nail Antirotation.

Authors:  Yuan Chen; Jun Qian; Yunji Zeng; Liangshan Huang; Yuanlei Zheng
Journal:  J Healthc Eng       Date:  2022-01-17       Impact factor: 2.682

3.  A succinct technique for the extraction of the proximal femoral nail anti-rotation (PFNA) after unlocking failure: a case report.

Authors:  Ming-de Cao; Zhong-Meng Yang; Hua-Ding Lu
Journal:  J Orthop Surg Res       Date:  2020-08-06       Impact factor: 2.359

4.  Biomechanical comparison of medial sustainable nail and proximal femoral nail antirotation in the treatment of an unstable intertrochanteric fracture.

Authors:  Shaobo Nie; Ming Li; Hui Ji; Zhirui Li; Wenwen Li; Hao Zhang; Zhang Licheng; Peifu Tang
Journal:  Bone Joint Res       Date:  2020-12       Impact factor: 4.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.